Composite medicament stent for inhibiting cardiovascular restenosis and preparation method

A restenosis and cardiovascular technology, which is applied in the field of composite drug stents and preparations for inhibiting cardiovascular restenosis, can solve the problems of ineffective endothelial effect of vascular endothelial progenitor cells, and achieve the goal of preventing thrombus, restenosis, and good activity Effect

Inactive Publication Date: 2010-10-27
赵菁
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the use of drug-coated stents has greatly reduced the occurrence of restenosis in stents. Although drug-eluting stents can effectively inhibit the proliferation of smoo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composite medicament stent for inhibiting cardiovascular restenosis and preparation method
  • Composite medicament stent for inhibiting cardiovascular restenosis and preparation method
  • Composite medicament stent for inhibiting cardiovascular restenosis and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0033] In a compound drug stent for inhibiting cardiovascular restenosis and its preparation method according to the present invention, the main body of the stent is made of metal pipes such as stainless steel, nickel-titanium alloy, cobalt-based alloy, magnesium alloy, cobalt-chromium alloy, etc., according to the pre-determined mesh shape by laser. Cutting, the surface of the stent is corroded by electrochemical acid solution to form nanopores, the surface of the main body is sprayed with a layer of non-degradable bioactive coating, the thickness is 10-50 microns, and another layer is sprayed on the outside of the non-degradable bioactive coating The degradable biocompatible polymer drug coating has a thickness of 10-100 microns. Among them, the non-degradable bioactive coating is made of a solution mixed with non-degradable biocompatible polymers, active biological components, organic solvents, etc., which are sprayed and dried; the drug coating is made of The mixed solutio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a composite medicament stent for inhibiting cardiovascular restenosis and a preparation method. The stent is prepared by performing laser cutting on a metal tube; the surface of the stent is corroded by electrochemical acid solution so as to form nanopores; the surface of a main body is coated with a nondegradable bioactive coating with thickness of 10 to 50 microns; a degradable biocompatible polymer medicament coating with thickness of 10 to 100 microns are coated outside the nondegradable bioactive coating; the nondegradable bioactive coating is prepared by mixing a nondegradable biocompatible high polymer, active biological components, an organic solvent and the like to form solution and spraying and drying the solution and the like; and the medicament coating is prepared by mixing a degradable biocompatible high polymer, anti-restenosis medicament ingredients, an organic solvent and the like to form solution and spraying and drying the solution and the like. The composite medicament stent has the characteristics of slow medicament release and capability of effectively reducing restenosis and thrombosis at the later stage of stent implantation.

Description

(1) Technical field [0001] The invention belongs to the field of medical equipment, and relates to a composite drug stent for inhibiting cardiovascular restenosis for minimally invasive interventional treatment of cardiovascular diseases and a preparation method thereof. (2) Background technology [0002] Coronary atherosclerotic heart disease is one of the important causes of death from cardiovascular diseases, and it is a common disease that seriously threatens human life and health. With the improvement of human living standards and the aging process of the population, the incidence of this disease is on the rise. In 1987, Sigwart and others used intravascular metal stents for the first time to treat coronary artery stenosis, and received ideal results. Since then, they have created a new way to treat various vascular blockages and stenosis diseases. At present, percutaneous coronary angioplasty (PTCA) has become a common method for clinical treatment of coronary heart d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L27/34A61L27/54A61L27/58A61F2/82A61L27/04A61L27/06
Inventor 赵菁
Owner 赵菁
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap